Back to Platforms

Platform 6: Diagnostics

This platform combines the expertise of three regional centres of excellence. It provides industry access to LSTM’s broad-based global expertise in diagnostics, break-through sensor technologies developed by Liverpool John Moore’s University’s BEST Research Institute, alongside world-leading surface analysis capability through the University of Liverpool’s Surface Science Research Centre.

Sensor technology with advanced AI analysis is being used to help develop point of use non-invasive diagnostics. These range from the measurement of parasites in peripheral blood to quantification of insecticide concentrations on a range of surfaces. The technology is designed to support the real-world development and evaluation of impactful non-invasive diagnostics to quality assure and monitor infectious disease prevention and treatment in order to better protect communities.

Our programme also helps to develop, evaluate and validate more standard point of care and PCR based diagnostics. Our team offers industry access to world-leading expertise and facilities that support every stage of the product journey, from early-stage concept, through evaluation and regulatory approval, to adoption through our FIND and WHO accredited facility. We work with industry to assess analytical sensitivity and efficacy in real-world settings, providing valuable insights to accelerate optimal diagnostic deployment. Industry partners benefit from a broad diagnostic focus and expertise across a range of platforms including lateral-flow, antibody, antigen, and molecular testing.

World-leading surface design and analysis, through the University of Liverpool’s Surface Science Research Centre, is enabling anti-infective and vector control surfaces to be evaluated, optimised and upscaled via knowledge-based engineering. This Interdisciplinary Research Centre features sophisticated surface sensitive spectroscopic and imaging techniques. These allow surfaces to be mapped at the nanoscale level and enables the interaction between technology and biological systems to be studied with precision., Our expertise is available to support industry in leveraging this technology to bring forward innovation in the anti-infective surfaces space.

For more information or to learn how your business can engage with this platform.

Email Dr Becky Jones-Phillips

Professor Andy Shaw

Platform Lead

Professor Andy Shaw

Head of the Built Environment and Sustainable Technology Research Institute (BEST) in the Faculty of Engineering and Technology at Liverpool John Moores University

Professor Shaw also leads the RF and Microwave (RFM) research theme within the institute. He graduated from the University of Liverpool with a BEng Hons in Electrical and Electronic engineering in 1990, a MSc in Materials Science (Engineering) in 1991 and a Ph.D. in 1995, titled “The realisation of an industrial free electron laser”. He worked as a postdoctoral researcher at the University of Liverpool for 8 years on industrial microwave applications for both material processing, sensor technologies and microwave plasma applications.

Read more
Professor Rasmita Raval

Platform Lead

Professor Rasmita Raval

Professor in Chemistry and Director of the Surface Science Research Centre at the University of Liverpool

Professor Raval is also the Director of ‘The Open Innovation Hub for Antimicrobial Surfaces’ and is one of the four co-directors of the UK ‘National Biofilms Innovation Centre’.

Read more
Dr Ana Isabel Cubas Atienzar

Platform Lead

Dr Ana Isabel Cubas Atienzar

Post-Doctoral Research Associate at Liverpool School of Tropical Medicine

Ana obtained her degree in Veterinary Medicine from the University of Murcia in 2013. In 2017 Ana obtained her PhD from the Salford University (UK). Her PhD focused on the epidemiology and genetic diversity of parasite Toxoplasma gondii in the Peninsula of Yucatan, Mexico. Shortly after her PhD she was appointed as Research Fellow at the Roslin Institute, in Edinburgh where she worked on diagnostic development for porcine viral and bacterial diseases.

Read more

Learn more about collaborating with iiCON

Discover more